Zenas Biopharma’s lead autoimmune drug has been tied to a 95% reduction in a type of brain lesions over 12 weeks in a phase 2 multiple sclerosis (MS) study.  | Zenas Biopharma’s lead autoimmune drug ...

A gene on the X chromosome revs up inflammation in the female brain, which may explain why rates of multiple sclerosis are ...

Scientists have found blood protein signals that may flag multiple sclerosis up to seven years before symptoms begin.

Radiomics offers improved assessment of spinal cord pathology in MS, surpassing conventional MRI in precision and sensitivity ...

Obexelimab almost completely prevented new inflammatory lesions visible on brain scans of adults with relapsing MS, per trial data.

The first patient has been dosed in a Phase 1 trial testing the experimental CAR T-cell therapy obecabtagene autoleucel for progressive MS.

Scientists found ALS and MS share a strong geographic pattern, suggesting common environmental causes behind both.

The new guidance for neurologists comes in updates to the McDonald criteria, the checklist doctors use to diagnose multiple sclerosis.

A new study published in Nature's Scientific Reports indicates that amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) have an extremely high geographic association, even after ...

Learn about multiple sclerosis, its symptoms, causes, and treatment options. Understand how early diagnosis helps in managing ...

Through many years of practicing I have had the privilege of working with women and men who struggle with various life issues, including eating disorders , marriage, trauma, grief and parenting.